Kettering Klaus, Greil Gerald F, Fenchel Michael, Kramer Ulrich, Weig Hans-Joerg, Busch Mathias, Miller Stephan, Sieverding Ludger, Laszlo Roman, Schreieck Juergen
Department of Cardiology, University of Mainz, Mainz, Germany.
Clin Res Cardiol. 2009 May;98(5):285-96. doi: 10.1007/s00392-009-0001-9. Epub 2009 Mar 13.
Catheter ablation has become the first line of therapy in patients with symptomatic, recurrent, drug refractory atrial fibrillation. However, catheter ablation of atrial fibrillation is still a challenge. This is partially due to the high degree of variability with regard to the individual anatomy. Nevertheless, 3D imaging systems (CT, MRI) provide detailed information about the individual left atrial and pulmonary vein morphology. A 3D CT or MRI reconstruction of the left atrium can be displayed in the Navx-/Ensite-system in a synchronised way during the ablation procedure, thereby facilitating the intervention. This study summarizes our preliminary experience with different strategies of AF ablation using the Navx-/Ensite-system and a CT-/MRI-guided approach.
In a total of 41 patients, cardiac MRI (n = 7) or multi-detector spiral computed tomography (n = 34) was performed prior to an ablation procedure. Catheter ablation was performed for paroxysmal atrial fibrillation in 31 patients and for persistent atrial fibrillation in 10 patients. A 3D MRI or high resolution spiral CT data acquisition was performed and a surface rendered model of the LA was created. This model was displayed in the Navx-/Ensite-system throughout the ablation procedure.
Catheter ablation was performed using the Navx-system (n = 38) or the Ensite-system (n = 3). Three strategies were used depending on the type of atrial fibrillation: segmental isolation of the pulmonary veins (facilitated by a 3D real-time visualization of the ablation catheter and a circumferential mapping catheter; group A: 20 patients), linear lesions (group C: 3 patients) and a combined approach (group B; 18 patients). The CT-/MRI-models provided an excellent overview over the pulmonary veins and the left atrial appendage. They revealed a high degree of variability with regard to the individual anatomy (e.g. dimensions of the left atrial appendage, pulmonary vein ostia). The CT scans provided a more detailed reconstruction of the left atrial anatomy than the MRI scans (especially in patients who were in atrial fibrillation at the time of the data acquisition). In some patients, the CT-/MRI-models revealed a very small diameter of some pulmonary veins or side branches close to the ostium (e.g. right inferior pulmonary vein). Therefore, no attempt was made to achieve complete pulmonary vein isolation in some patients. In group A, 16/20 (80%) patients had no arrhythmia recurrence [mean follow-up 359 days (SD +/- 317 days)]. Twelve out of eighteen (67%) patients in group B [mean follow-up 452 days (SD +/- 311 days)] and 2/3 (67%) patients in group C did not experience an arrhythmia recurrence [mean follow-up 1,000 days (SD +/- 34 days)]. There were no major complications.
The information derived from 3D CT- or MRI-reconstructions facilitates AF ablations performed with the Navx-/Ensite-mapping system and enhances the safety of these procedures. Furthermore, the availability of an additional impedance-based 3D real-time visualization of the ablation catheter and the circular mapping catheter placed in the pulmonary veins represents a major advantage of the Navx system.
导管消融已成为有症状的、复发性、药物难治性心房颤动患者的一线治疗方法。然而,心房颤动的导管消融仍然是一项挑战。部分原因是个体解剖结构存在高度变异性。尽管如此,三维成像系统(CT、MRI)可提供有关个体左心房和肺静脉形态的详细信息。在消融过程中,左心房的三维CT或MRI重建图像可在Navx-/Ensite系统中同步显示,从而便于进行干预。本研究总结了我们使用Navx-/Ensite系统及CT-/MRI引导方法进行不同策略房颤消融的初步经验。
共41例患者在消融术前接受了心脏MRI检查(n = 7)或多排螺旋计算机断层扫描(n = 34)。31例阵发性心房颤动患者和10例持续性心房颤动患者接受了导管消融。进行了三维MRI或高分辨率螺旋CT数据采集,并创建了左心房的表面渲染模型。在整个消融过程中,该模型显示于Navx-/Ensite系统中。
使用Navx系统(n = 38)或Ensite系统(n = 3)进行导管消融。根据房颤类型采用了三种策略:肺静脉节段隔离(借助消融导管和环形标测导管的三维实时可视化;A组:20例患者)、线性消融(C组:3例患者)和联合方法(B组:18例患者)。CT-/MRI模型能很好地显示肺静脉和左心耳。它们显示出个体解剖结构存在高度变异性(如左心耳尺寸、肺静脉开口)。CT扫描比MRI扫描能更详细地重建左心房解剖结构(尤其是在数据采集时处于房颤状态的患者)。在一些患者中,CT-/MRI模型显示某些肺静脉或靠近开口处的分支直径非常小(如右下肺静脉)。因此,在一些患者中未尝试实现完全肺静脉隔离。A组中,16/20(80%)例患者无心律失常复发[平均随访359天(标准差±317天)]。B组18例患者中有12例(67%)[平均随访452天(标准差±311天)],C组3例患者中有2例(67%)未出现心律失常复发[平均随访1000天(标准差±34天)]。无重大并发症。
三维CT或MRI重建获得的信息有助于使用Navx-/Ensite标测系统进行房颤消融,并提高这些操作的安全性。此外,Navx系统的一个主要优势是可额外提供基于阻抗的消融导管和置于肺静脉中的环形标测导管的三维实时可视化。